• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-Deoxy-D-Glucose (2DG)
      • Acacia Cyanophylla Flower
      • Acori Graminei Rhizoma
      • Aegle Marmelos Correa
      • Agaricus Blazei
      • Aged Garlic Extract
      • Aframomum Melegueta
      • Aloe Arborescens
      • Albizia
      • Alpinia Officinarum
      • Alternanthera Sessilis
      • American Ginseng
      • Amygdalin
      • Anacyclus Pyrethrum
      • Angelica Archangelica
      • Angelica Sinensis
      • Antrodia
      • Artichoke Leaf
      • Artocarpin
      • Ajuga Turkestanica
      • Ashwagandha
      • Aspalathin
      • Astragalus Complanatus
      • Avena Sativa
      • Bacopa Monnieri
      • Bavachin
      • Bee Pollen
      • Betulinic Acid
      • Boswellic Acid
      • Brevilin A
      • Campesterol
      • Casticin
      • Chrysin
      • Cinnamomum Zeylanicum
      • Citrullus Colocynthis
      • Citrus Reticulata Peel
      • Codonopsis
      • Costunolide
      • Cucurbitacin D
      • Daidzein
      • Decursin
      • Delphinidin
      • Digitalis Purprea (Digoxin)
      • Diosmin
      • Embelin
      • Gallic Acid
      • Glycitein
      • Glycyrrhizin
      • Hyperforin
      • Icariin
      • Isorhamnetin
      • Isoorientin
      • Isovitexin
      • Jaceosidin
      • Kaempferol
      • Kurarinone
      • Lemon balm
      • Licoricidin
      • Lipoic acid
      • Lupeol
      • Magnolol
      • Mulberry Leaf
      • Naringenin
      • Nobiletin
      • Oleacein
      • Oleanolic acid
      • Oridonin
      • Parthenolide
      • Phloroglucinol
      • Piceatannol
      • Pristimerin
      • Proanthocyanidins
      • Procyanidin B3
      • Pseudolaric acid b
      • Pterostilbene
      • Rutin
      • Solidago Virgaurea
      • Tangeretin
      • Taraxasterol
      • Trichostatin A
      • Wedelolactone
      • Wogonin
      • Yerba Mate
    • ABOUT
    • SCIENTIFIC STUDIES
      • ALLERGIES & CYTOKINES
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • AMPK
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI COVID-19 EFFECTS OF FLAVONOIDS AND POLYPHENOLS (1000 SCIENTIFIC STUDIES)
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • APOPTOSIS
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • CARDIAC GLYCOSIDES
      • CENTENARIANS
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • EPIGENETIC MODIFIERS
      • FGF21
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HMGB1
      • HSP90 INHIBITORS
      • HYPERINSULINEMIA
      • IKK
      • IL-6/STAT3
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INSULIN & AGING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTOR: THE RAPID AGING PATHWAY
      • NEUROINFLAMMATION
      • NMDA & ANXIETY & DEPRESSION
      • NOOTROPICS
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PHYTOECDYSTEROIDS
      • PPARY2
      • PREMATURE SENESCENCE
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAT3
      • TELOMERE SHORTENING & PREMATURE AGING
    • HOME
    • FAQ
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    DIGITALIS PURPUREA (DIGOXIN)
    January 29, 2020
    INFLAMMAGING
    January 29, 2020
    1. … (notably the C-glycosides carlinoside, isoorientin, isoscoparin, neocarlinoside, schaftoside and neoschafto-side); oestrogenic (Wogonin); and oviposition stimulants …
    2. … and Biopharmaceutics Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and Wogonin to breast cancer
    3. … LC-MS/MS assay for the determination of Wogonin: Application to a preclinical pharmacokinetics and bioavailability of different Wogonin administration in beagle dogs
    4. … of inflammation‐associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by Wogonin …
    5. < Originals> Inhibitory effects of baicalein and Wogonin on the growth of B16 melanoma cells
    6. 290. The constitution of oroxylin-A. Part II. Attempted synthesis of oroxylin-A and the synthesis of Wogonin
    7. A flavone, Wogonin from Scutellaria baicalensis inhibits the proliferation of human colorectal cancer cells by inducing of autophagy, apoptosis and G2/M cell …
    8. A novel process related impurity and forced degradation study of synthetic Wogonin: Development of a liquid chromatographic method for purity control
    9. A novel prostate-specific membrane-antigen (PSMA) targeted micelle-encapsulating Wogonin inhibits prostate cancer cell proliferation via inducing intrinsic apoptotic …
    10. A nti-Hepatic Cirrhosis E ffects of Schizandrin, Glycyrrhizinic acid and Wogonin on TAA-induced Hepatic Cirrhosis in Primary Cultured Rat Hepatocyte and …
    11. A Practical and Efficient Approach to the Preparation of Bioactive Natural Product Wogonin
    12. A Wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects
    13. A Wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA …
    14. Abstract C99: Wogonin enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by Nrf2 suppression in …
    15. Activities of Wogonin Analogs and Other Flavones against Flavobacterium columnare
    16. Acute lung injury induced by lipopolysaccharide is inhibited by Wogonin in mice via reduction of Akt phosphorylation and RhoA activation
    17. Acute Toxicity Test of Wogonin in Mice
    18. Advance in studies on antitumor and immunomodulatory effects of Wogonin
    19. Advances of Wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
    20. Aislamiento selectivo y de alto rendimiento de Wogonin puro a partir de partes aéreas de Scutellaria havanensis Jacq.
    21. An enhanced preparation and purification of the major antioxidants baicalein and Wogonin from Scutellariae radix
    22. An overview and comparison of a recombinant antigen-binding fragment and an antigen-binding fragment from a monoclonal antibody against Wogonin glucuronide
    23. Analysis and comparison of baicalin, baicalein and Wogonin contents in traditional decoctions and commercial extracts of Scutellariae radix
    24. Analysis of baicalein, baicalin and Wogonin in Scutellariae radix and its preparation by microemulsion electrokinetic chromatography with 1-butyl-3-methylimizolium …
    25. Anti-cancer scopes and associated mechanisms of Scutellaria extract and flavonoid Wogonin
    26. Anti-fibrotic effect of Wogonin in renal tubular epithelial cells via Smad3-dependent mechanisms
    27. Anti-hepatitis B virus activity of Wogonin in vitro and in vivo
    28. Anti-hepatitis B virus effects of Wogonin isolated from Scutellaria baicalensis
    29. Anti-inflammatory effect of Wogonin on allergic responses in ovalbumin-induced allergic rhinitis in the mouse
    30. Anti-inflammatory effect of Wogonin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid
    31. Anti-inflammatory Effects of Baicalin, Baicalein, and Wogonin In Vitro and In Vivo
    32. Anti-Proliferative Effect of Wogonin on Ovary Cancer Cells Involves Activation of Apoptosis and Cell Cycle Arrest
    33. Anti-tumor activity of Wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways
    34. Anti-tumor and anti-metastatic actions of Wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis
    35. Anticancer effect of nor-Wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
    36. Anticancer effects of Wogonin in both estrogen receptor‐positive and ‐negative human breast cancer cell lines in vitro and in nude mice xenografts
    37. Anticoagulant effect of Wogonin against tissue factor expression
    38. Anticonvulsant effect of Wogonin isolated from Scutellaria baicalensis
    39. Antifungal activity of Wogonin
    40. Antioxidant and free radical scavenging effects of baicalein, baicalin and Wogonin.
    41. Antithrombotic activities of Wogonin and wogonoside via inhibiting platelet aggregation
    42. Antitumor actions of baicalein and Wogonin in HT-29 human colorectal cancer cells
    43. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and Wogonin on bladder cancer cell lines
    44. Anxiolytic effect of Wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi
    45. Apigenin and Wogonin regulate epidermal growth factor receptor signaling pathway involved in MUC5AC mucin gene expression and production from …
    46. Apoptosis induction and imaging of cadmium-telluride quantum dots with Wogonin in multidrug-resistant leukemia K562/A02 cell
    47. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic ferroferric oxide nanoparticles loaded with Wogonin
    48. Application of Wogonin for preparing medicine to treat or prevent hepatitis B
    49. Application of Wogonin in the preparing of medicine for treating gastric cancer
    50. Baicalein and Wogonin are activators of rat TREK‐2 two‐pore domain K+ channel
    51. Baicalein and Wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures
    52. Baicalein, Wogonin, and Scutellaria baicalensis ethanol extract alleviate ovalbumin-induced allergic airway inflammation and mast cell-mediated anaphylactic …
    53. Baicalin, baicalein and Wogonin inhibits high glucose-induced vascular inflammation in vitro and in vivo
    54. Binding of Wogonin to human gammaglobulin
    55. Binding of Wogonin to human serum albumin: a common binding site of Wogonin in subdomain IIA
    56. BisGMA‐induced cytotoxicity and genotoxicity in macrophages are attenuated by Wogonin via reduction of intrinsic caspase pathway activation
    57. BM microenvironmental protection of CML cells from imatinib through Stat5/NF-κB signaling and reversal by Wogonin
    58. C36 NOVEL MECHANISMS OF ALLERGIC AIRWAY INFLAMMATION IN ANIMAL MODELS: Wogonin Attenuates Allergic Neutrophilic Airway Inflammation By …
    59. Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?
    60. Cardio protective role of Wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation
    61. Catalase suppression‐mediated H2O2 accumulation in cancer cells by Wogonin effectively blocks tumor necrosis factor‐induced NF‐κB activation and sensitizes …
    62. Changes in mitochondrial membrane potential and reactive oxygen species during Wogonin‐induced cell death in human hepatoma cells
    63. Characterization and bioavailability of Wogonin by different administration routes in beagles
    64. Chinese herbal remedy Wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells
    65. Chondroprotective effects of Wogonin in experimental models of osteoarthritis in vitro and in vivo
    66. Combination of icotinib and Wogonin induces apoptosis and autophagy to overcome acquired resistance in lung cancer harbouring EGFR T790M mutation
    67. Combination of Wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition
    68. Combined activity of oridonin and Wogonin in advanced-stage ovarian cancer cells
    69. Comparative pharmacokinetic and tissue distribution study of baicalin, baicalein, wogonoside, Wogonin and oroxylin-A after oral administration of Component …
    70. Comparative pharmacokinetics of baicalin, wogonoside, baicalein and Wogonin in plasma after oral administration of pure baicalin, radix scutellariae and …
    71. Convenient synthesis of Wogonin, a flavonoid natural product with extensive pharmacological activity
    72. Correction: Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-κB Signaling after Experimental Traumatic Brain Injury
    73. Corrigendum to” Inhibitory effects of Wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix …
    74. Corrigendum to” Selective anti-tumor activity of Wogonin targeting the Warburg effect through stablizing p53″[Pharmacol. Res. 135 (2018) 49-59].
    75. Corrigendum to” Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1″[Toxicology 305 (2013) 10-19].
    76. Corrigendum to” Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein”[Toxicology and Applied Pharmacology 271 (2013) 144-145].
    77. Cryptotanshinone and Wogonin up-regulate eNOS in vascular endothelial cells via ERα and down-regulate iNOS in LPS stimulated vascular smooth muscle cells via …
    78. Cytotoxicity and radiosensitizing effect of Wogonin, an extract from Scutellaria litwinowii, in head and neck squamous cell carcinoma line HN5.
    79. Dataset of effect of Wogonin, a natural flavonoid, on the viability and activation of NF-κB and MAPKs in IL-1β-stimulated human OA chondrocytes
    80. Design of Wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity
    81. Determination of baicalin and Wogonin in Chantui Zhike Granules by HPLC
    82. Determination of Baicalin and Wogonin in Tongjing Patch by HPLC
    83. Determination of Baicalin and Wogonin in XiaoErReSuQing Granules by HPLC [J]
    84. Determination of Baicalin, Baicalein and Wogonin in Ten Wild Scutellaria baicalensis from Shanxi
    85. Determination of Berberine Hydrochloride, Baicalin and Wogonin in Yankening Pian by HPLC
    86. Determination of gentiopicroside, mangiferin, palmatine, berberine, baicalin, Wogonin and glycyrrhizin in the traditional Chinese medicinal preparation Sann …
    87. Determination of GL‐V9, a derivative of Wogonin, in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study after oral and pulmonary …
    88. Determination of pK a values of wogonoside, Wogonin and oroxylin-A by RP-HPLC
    89. Determination of Wogonin in rat plasma by liquid chromatography and its pharmacokinetic application
    90. Determination of Wogonin in rat plasma by liquid chromatography-tandem mass spectrometry
    91. Determination on the Content of Wogonin in Qinzhu Tongjing Patch by HPLC
    92. Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, Wogonin, oroxylin A and their glucuronides baicalin, wogonoside and …
    93. Development of an immunoassay using an anti-Wogonin glucuronide monoclonal antibody
    94. Development of new HPLC method for Wogonin in rat plasma: Compatibility of standard and test samples
    95. Developmental toxicity and genotoxicity studies of Wogonin
    96. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid Wogonin among human cancer cells and normal diploid cell
    97. Different apoptotic effects of Wogonin via induction of H2O2 generation and Ca2+ overload in malignant hepatoma and normal hepatic cells
    98. Different effects of baicalein, baicalin and Wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines
    99. Differential apoptotic effect of Wogonin and nor‐Wogonin via stimulation of ROS production in human leukemia cells
    100. Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro
    101. Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
    102. Drug resistance associates with activation of Nrf2 in MCF‐7/DOX cells, and Wogonin reverses it by down‐regulating Nrf2‐mediated cellular defense response
    103. Dual Effect of Wogonin on TREK-2 Expression and Channel Activity
    104. Effect and mechanism of Wogonin on NF-κB nuclear translocation and expression in NR8383 cells infected by influenza virus [J]
    105. Effect of magnetic nanoparticles of Fe3O4 and Wogonin on the reversal of multidrug resistance in K562/A02 cell line
    106. Effect of magnetic nanoparticles on apoptosis and cell cycle induced by Wogonin in Raji cells
    107. Effect of Wogonin on OSCC cell growth and invasion
    108. Effect of Wogonin on OSCC cell growth and invasion
    109. Effect of Wogonin on osteosarcoma cells and its mechanism based on a PI3K/Akt signaling pathway
    110. Effect of Wogonin on spatial memory and its possible mechanisms in chronic cerebral ischemia in rats
    111. Effect of Wogonin on the Proliferation in Acute Myeloid Leukemia HL-60 Cell Through Inhibition of PI3K/Akt/mTOR Signaling Pathway
    112. Effect of Wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthase in …
    113. Effects of baicalein and Wogonin isolated from Scutellaria baicalensis roots on skin damage in acute UVB-irradiated hairless mice
    114. Effects of baicalein and Wogonin on drug-metabolizing enzymes in C57BL/6J mice
    115. Effects of baicalin and Wogonin on mucin release from cultured airway epithelial cells
    116. Effects of baicalin, baicalein, and Wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-κb binding activities induced by interleukin-1β in human …
    117. Effects of scutellariae radix extract and its components (baicalein, baicalin, and Wogonin) on the experimental elevation of aqueous flare in pigmented rabbits
    118. Effects of the Wogonin on LPS induced iNOS expression in BV2 cells
    119. Effects of Wogonin on Apoptosis, Invasion, Migration and Wnt/β-Catenin Signaling Pathway of Gastric Cancer Cells SGC7901
    120. Effects of Wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity
    121. Effects of Wogonin on inflammation-related factors in alveolar macrophages infected with influenza virus [J]
    122. Effects of Wogonin on LPS-induced IL-6 and RANTES production [J]
    123. Effects of Wogonin on LPS-induced NO and MCP-1 production
    124. Effects of Wogonin on LPS-induced production of proinflammatory cytokines [J]
    125. Effects of Wogonin on Proliferation and Cell Cycle of SPC-A-1 Cells
    126. Effects of Wogonin on the Apoptosis of Human Glioma Cell Line U251 [J]
    127. Effects of Wogonin on the levels of cytokines and functions of leukocytes associated with NF-kappa B expression in Sprague-Dawley rats
    128. Effects of Wogonin on the mechanism of melanin synthesis in A375 cells
    129. Effects of Wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression
    130. Effects of Wogonin, wogonoside, and 3, 5, 7, 2′, 6′-pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat …
    131. Efficacy of Wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium
    132. Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by Wogonin via the PI3K/Akt pathway
    133. Enhancement of solubility and dissolution rate of baicalein, Wogonin and oroxylin A extracted from Radix scutellariae
    134. Enzymatic extraction of baicalein and Wogonin from radix scutellariae
    135. Experimental study on inhibitory effect of Wogonin on proliferation and invasion of breast cancer cells
    136. Flavonoid Wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia
    137. Functional role of Wogonin in anti-angiogenesis
    138. Genetic and Environmental Variations in Baicalin, Baicalein and Wogonin Contents in Scutellaria baicalensis
    139. GSK3β/β-catenin signaling is correlated with the differentiation of glioma cells induced by Wogonin
    140. High-yield production of scutellaria radix flavonoids (baicalein, baicalin and Wogonin) by liquid-culture of Scutellaria baicalensis root-derived cells
    141. High‐dose Wogonin exacerbates DSS‐induced colitis by up‐regulating effector T cell function and inhibiting Treg cell
    142. Histopathological Comparison of Animal Models of Skin Inflammation and Inhibition of the Inflammatory Responses by Plant Flavonoid, Wogonin
    143. Identification and quantification of baicalein, Wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix …
    144. In vitro and in vivo inhibitory activities of rutin, Wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production
    145. In Vitro Inhibitory Effect of Wogonin on Human Osteosarcoma
    146. In Vivo Hepatoprotective Effect of Baicalein, Baicalin and Wogonin from Scutellaria rivularis
    147. In vivo pharmacokinetics and tissue distribution of Wogonin albumin microspheres in rats [J]
    148. Influence of Adriamycin and Wogonin on the Expression of Mir-155 in Burrkit Lymphoma in Vitro
    149. Inhibition of breast cancer metastases to bone by baicalein, baicalin and Wogonin derived from Scutellaria radix
    150. Inhibition of contact dermatitis in animal models and suppression of proinflammatory gene expression by topically applied flavonoid, Wogonin
    151. Inhibition of Lithium Sensitive Orai1/STIM1 Expression and Store Operated Ca2+ Entry in Chorea-Acanthocytosis Neurons by NF-κB Inhibitor Wogonin
    152. Inhibition of Lung Cancer Proliferation by Wogonin is Associated with Activation of Apoptosis and Generation of Reactive Oxygen Species
    153. Inhibition of prostaglandin E2 production by synthetic Wogonin analogs
    154. Inhibition of TNF‐α‐induced MUC5AC mucin gene expression and production by Wogonin through the inactivation of NF‐κB signaling in airway epithelial cells
    155. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by Wogonin, a plant flavone from Scutellaria radix
    156. Inhibitory effect of baicalin, baicalein and Wogonin on secretory group IIA phospholipase A2
    157. Inhibitory effect of Wogonin on gastric cancer SGC7901 cell line in vitro
    158. Inhibitory effect of Wogonin on the mouse ascites hepatocarcinoma and its mechanism
    159. Inhibitory effect of Wogonin on the proliferation and invasion of glioblastoma U87 cells and related mechanism
    160. Inhibitory effects of baicalein and Wogonin on lipopolysaccharide‐induced nitric oxide production in macrophages
    161. Inhibitory effects of Wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes
    162. Inhibitory effects of Wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen …
    163. Inhibitory effects of Wogonin on lung cancer A549 cell line in vitro.
    164. Inhibitory effects of Wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9
    165. Interaction of Wogonin with bovine serum albumin
    166. Intervention impact of Wogonin on type 1 diabetic mice and its influence on p62dok expression in liver
    167. Involvement of bax/bcl-2 in Wogonin-induced apoptosis of human hepatoma cell line SMMC-7721
    168. Isolation and purification of baicalein, Wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography
    169. Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and Wogonin in rat plasma
    170. Main signal pathways underlying the molecular mechanisms of the antitumor effects of Wogonin
    171. Mechanism in the existent difference in form of Wogonin/wogonoside between plasma and intestine/liver in rats
    172. Mechanism of Wogonin-mediated sensitization of HTLV-1-associated ATL cells to TRAIL-induced apoptosis
    173. Mechanism research of proliferation and killing hepatoma cell of CD3AK cell by Wogonin
    174. Mechanistic study of absorption and first‐pass metabolism of GL‐V9, a derivative of Wogonin
    175. Mediating macrophage immunity with Wogonin in mice with vascular inflammation
    176. Molecular characterization of flavonoid biosynthetic genes and accumulation of baicalin, baicalein, and Wogonin in plant and hairy root of Scutellaria …
    177. Molecular Mechanism of Wogonin Inhibiting Hepatocellular Cancer Cells Growth by Gene Chip
    178. Nephroprotective effect of Wogonin against cadmium-induced nephrotoxicity via inhibition of oxidative stress–induced MAPK and NF-kB pathway in Sprague Dawley …
    179. Neuroprotective effect of Wogonin in a rodent model of permanent focal cerebral ischemia
    180. Neuroprotective effect of Wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
    181. Neuroprotective effect of Wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation
    182. Neuroprotective effect of Wogonin on Rat’s brain exposed to gamma irradiation
    183. Neuroprotective effect of Wogonin: potential roles of inflammatory cytokines
    184. Neuroprotective effects of baicalein, baicalin, and Wogonin in primary cuItured rat cortical cells
    185. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
    186. NF-κ B and Nrf2 signaling pathways contribute to Wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis
    187. Novel platinum (IV) complexes conjugated with a Wogonin derivative as multi-targeted anticancer agents
    188. O-methylated Flavone Wogonin Specifically Reduces Melanosome Transport through Downregulation of Melanophilin
    189. P23. Inhibitory effects of baicalein, baicalin and Wogonin on osteolytic bone metastasis of breast cancer
    190. Pharmacokinetic properties of Wogonin and its herb–drug interactions with docetaxel in rats with mammary tumors
    191. Pharmacokinetics of baicalein, baicalin and Wogonin after oral administration of a standardized extract ofScutellaria baicalensis, PF-2405 in rats
    192. Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of Wogonin in rats
    193. Phorbol ester or epidermal growth‐factor‐induced MUC5AC mucin gene expression and production from airway epithelial cells are inhibited by apigenin and Wogonin
    194. Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by Wogonin from Scutellaria baicalensis Georgi
    195. Potential therapeutic effects of baicalein, baicalin, and Wogonin in ocular disorders
    196. Preliminary Research on the Inducing Effects of Wogonin on the Apoptosis of Lung Cancer Cells and Its Mechanism
    197. Preparation and in vitro Drug Release of Wogonin-loaded Solid Lipid Nanoparticles
    198. Preparation and its in vitro release of Wogonin albumin microspheres [J]
    199. Preparation of Wogonin from Radix Scutellariae and its Inhibitory Effects on the Growth of HepG2 Cells
    200. Prevention of Wogonin on colorectal cancer tumorigenesis by regulating p53 nuclear translocation
    201. Preventive effect of the flavonoid, Wogonin, against ethanol-induced gastric mucosal damage in rats
    202. Probe substrate and enzyme source-dependent inhibition of UDP-glucuronosyltransferase (UGT) 1A9 by Wogonin
    203. Progress on inclusion complexes of baicalein and Wogonin with cyclodextrins
    204. Protection Effect of Wogonin on Mice with Hyperlipidemia
    205. Protective effect of Wogonin on endotoxin‐induced acute lung injury via reduction of p38 MAPK and JNK phosphorylation
    206. Protective Effect of Wogonin on Endotoxin‐Induced Lethal Shock in D‐Galactosamine‐Sensitized Mice
    207. Protective effect of Wogonin on proinflammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccharide stimulated BV2 microglial cells
    208. Protective effects of baicalein and Wogonin against benzo [a] pyrene-and aflatoxin B1-induced genotoxicities
    209. Protective effects of baicalein and Wogonin against mutagen-induced genotoxicities
    210. Protective effects of Wogonin against Alzheimer’s disease by inhibition of amyloidogenic pathway
    211. Protective role of Wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1
    212. Quantitation of the flavonoid Wogonin and its major metabolite Wogonin-7β-d-glucuronide in rat plasma by liquid chromatography–tandem mass spectrometry
    213. Reactive oxygen species up‐regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and Wogonin
    214. Recombinant soluble CD40 ligand enhances Wogonin-induced antitumor activity
    215. Relaxant effect induced by Wogonin from Scutellaria baicalensis on rat isolated uterine smooth muscle
    216. Research of Wogonin enchancing the sensitivity of A549 cells to TRAIL-induced apoptosis
    217. Response of human non-small-cell lung cancer cells to the influence of Wogonin with SGK1 dynamics
    218. Reversal of cisplatin resistance in human gastric cancer cells by a Wogonin-conjugated Pt (IV) prodrug via attenuating Casein Kinase 2-mediated Nuclear Factor-κB …
    219. Role of p53, PUMA, and Bax in Wogonin-induced apoptosis in human cancer cells
    220. Scutellaria extract and Wogonin inhibit tumor-mediated induction of Treg cells via inhibition of TGF-β1 activity
    221. Selective and high yield isolation of pure Wogonin from aerial parts of Scutellaria havanensis Jacq
    222. Selective anti-tumor activity of Wogonin targeting the Warburg effect through stablizing p53
    223. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and Wogonin to breast cancer
    224. Simulatneous determination of baicalein, Wogonin, oroxylin-A and their glucuronides in scutellariae radix by ion-pair high-performance liquid chromatography
    225. Simultaneous determination of aloe-emodin, rhein, emodin, physcion, chrysophanol, baicalin, Wogonin, berberine hydrochloride in Yiqing granules by HPLC [J]
    226. Simultaneous determination of baicalein and Wogonin in Chinese medicinal plant Scutellaria baicalensis using HPLC–DAD coupled with alternating trilinear …
    227. Simultaneous determination of baicalein, baicalin, Wogonin, and wogonoside in rat plasma by LC-MS/MS for studying the pharmacokinetics of the standardized extract …
    228. Simultaneous determination of baicalein, chrysin and Wogonin in four Iranian Scutellaria species by high performance liquid chromatography
    229. Simultaneous Determination of Baicalein, Wogonin and its Glycosides in Scutellariae Radix Extract by HPLC in Isocratic Mode.
    230. Simultaneous determination of baicalin, baicalein and Wogonin in Qinlian tablets by HPLC [J]
    231. Simultaneous Determination of Baicalin, Baicalein and Wogonin In Radix Scutellariae by HPLC [J]
    232. Simultaneous determination of baicalin, baicalein and Wogonin in Xiaoyan tablets by HPLC
    233. Simultaneous determination of baicalin, baicalein, Wogonin, berberine, palmatine and jatrorrhizine in rat plasma by liquid chromatography–tandem mass spectrometry …
    234. Simultaneous determination of baicalin, baicalein, Wogonin, oxysophocarpine, oxymatrine and matrine in the chinese herbal preparation of sanwu-huangqin-tang by …
    235. Simultaneous determination of baicalin, baicalein, wogonoside, Wogonin, scutellarin, berberine, coptisine, ginsenoside Rb1 and ginsenoside Re of Banxia xiexin …
    236. Simultaneous determination of baicalin, wogonoside, baicalein, Wogonin, berberine, coptisine, palmatine, jateorrhizine and glycyrrhizin in Kampo medicines by ion …
    237. Simultaneous determination of baicalin, wogonoside, baicalein, Wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography …
    238. Simultaneous Determination of Chlorogenic Acid, Forsythin, Baicalin and Wogonin in Shuanghuanglian Oral Liquid by Wavelength Conversion HPLC [J]
    239. Simultaneous determination of sodium salvianic A baicalin, baicalein, Wogonin, wogonoside and tanshinone A in chidan pills by HPLC
    240. Simultaneous Determination of Sodium Salvianic A Baicalin, Baicalein, Wogonin, Wogonoside and TanshinoneⅡA in Chidan Pills by HPLC
    241. Simultaneous determination of Wogonin, oroxylin a, schisandrin, paeoniflorin and emodin in rat serum by HPLC–MS/MS and application to pharmacokinetic studies
    242. Simultaneous Determination of Wogonin, Scutellarin, Baicalin, and Baicalein in Extracts from Scutellariae Baicalensis by High-Performance Liquid Chromatography …
    243. Simultaneous LC–MS Analysis and of Wogonin and oroxylin a in rat plasma, and pharmacokinetic studies after administration of the active fraction from Xiao-Xu-Ming …
    244. Skullcap (Scutellaria baicalensis) extract and its active compound, Wogonin, inhibit ovalbumin-induced Th2-mediated response
    245. SPE and LC for analysis of the tissue distribution of Wogonin and its metabolite in tumor-bearing nude mice
    246. Strong inhibition capability of Wogonin towards UDP-glucuronosyltransferase (UGT) 1A1 and 1A3
    247. Structure and antiinflammatory activity relationships of Wogonin derivatives
    248. Structure-activity relationship study between baicalein and Wogonin by spectrometry, molecular docking and microcalorimetry
    249. Study of the inclusion complex and antioxidating activity of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
    250. Study on extraction and isolation of Wogonin from the root of Scutellaria [J]
    251. Study on Pharmacokinetics and Distribution of Wogonin Solid Lipid Nanoparticles in Rats
    252. Study on plasma concentration and bioavailability of Wogonin in Beagle’s dogs
    253. Study on Plasma Concentration and Bioavailability of Wogonin in Beagle’s Dogs
    254. Study on the Effect of Wogonin on Telomerase Gene of Nude Mice with Transplanted Human Ovarian Cancer SKOV3 Cells and its Relationship with Apoptosis [J]
    255. Studying on inclusion complexes of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
    256. Subchronic toxicity and plasma pharmacokinetic studies on Wogonin, a natural flavonoid, in Beagle dogs
    257. Suppression of cyclooxygenase-2 expression of skin fibroblasts by Wogonin, a plant flavone from Scutellaria radix
    258. Sustained cytotoxicity of Wogonin on breast cancer cells by encapsulation in solid lipid nanoparticles
    259. Sustained Effect of Wogonin-loaded Solid Lipid Nanoparticles on Apoptosis in MCF-7 Cells
    260. Synergistic effect of baicalein, Wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of …
    261. Synergistic effect of baicalein, Wogonin and oroxylin A mixture: multistep inhibition of the NF-κB signalling pathway contributes to an anti-inflammatory effect of …
    262. Synergistic inhibitory effect of Wogonin and low-dose paclitaxel on gastric cancer cells and tumor xenografts
    263. Synthesis of Wogonin Analogs and Their Biological Effects
    264. Synthesis, characterization and bacteriastatic activities of Wogonin and its Cu (Ⅱ), Co (Ⅱ), Ni (Ⅱ) complexes [J]
    265. Synthesis, characterize and antioxidating activity of the inclusion complex of Wogonin with β-cyclodextrin and hydroxypropyl-cyclodextrin
    266. Synthesis, evaluation and quantitative structure–activity relationship (QSAR) analysis of Wogonin derivatives as cytotoxic agents
    267. Synthesis, Investigation on Immunity and Cancer Prevention of Wogonin Derivatives
    268. Synthetic Wogonin derivatives suppress lipopolysaccharide-induced nitric oxide production and hydrogen peroxide-induced cytotoxicity
    269. Targeting CDK9 by Wogonin and related natural flavones potentiates the anti‐cancer efficacy of the Bcl‐2 family inhibitor ABT‐263
    270. Targeting Nrf2 with Wogonin overcomes cisplatin resistance in head and neck cancer
    271. The Anti-inflammatory Activity of Scutellaria rivularis Extracts and Its Active Components, Baicalin, Baicalein and Wogonin
    272. The anticancer activities of Wogonin in murine sarcoma S180 both in vitro and in vivo
    273. The Antitumor effect of Wogonin, a lipoxygenase inhibitor, in both estrogen receptor-positive and-negative human breast cancers.
    274. The effect of varying the peptide linker length in a single chain variable fragment antibody against Wogonin glucuronide
    275. The Establishment of the Quantitative Model of Wogonin in Radix Scutellariae
    276. The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling
    277. The inhibitory role of Wogonin on tumor growth and telomerase activity of human ovarian cancer SKOV3 cell line xenograf in nude mice
    278. The inhibitory role of Wogonin on tumor growth and telomerase activity of human ovarian cancer SKOV3 cell line xenograf in nude mice
    279. The mitochondrial pathway in baicalein and Wogonin-induced apoptosis in human colorectal cancer cells
    280. The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and Wogonin
    281. The plant flavonoid Wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production
    282. The Quantitative Study on Baicalin and Wogonin of Radix Scutellariae by Self Enz ymatic Hydrolysis [J]
    283. The reference genome sequence of Scutellaria baicalensis provides insights into the evolution of Wogonin biosynthesis
    284. The role of Wogonin in controlling SOCS3 expression in neuronal cells
    285. Themes: Title: Study of Wogonin & radiotherapy-induced cytotoxicity and apoptosis in HN5cell line
    286. Therapeutic potential of Wogonin: a naturally occurring flavonoid
    287. Therapy effects of Wogonin on ovarian cancer cells
    288. TNF receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid Wogonin
    289. Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis
    290. Toxicological studies of Wogonin in experimental animals
    291. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid Wogonin
    292. Tumor necrosis factor-producing activity of Wogonin in RAW 264.7 murine macrophage cell line
    293. Urinary pharmacokinetics of baicalein, Wogonin and their glycosides after oral administration of Scutellariae Radix in humans
    294. Use of isoform-specific UGT metabolism to determine and describe rates and profiles of glucuronidation of Wogonin and oroxylin A by human liver and intestinal …
    295. Vascular barrier protective effects of baicalin, baicalein and Wogonin in vitro and in vivo
    296. Vascular relaxation induced by Eucommiae Ulmoides Oliv. and its compounds Oroxylin A and Wogonin: implications on their cytoprotection action
    297. Vasodilatory effect of Wogonin on the rat aorta and its mechanism study
    298. Wogonin a Promising Component of Scutellaria baicalensis: A Review on its Chemistry, Pharmacokinetics and Biological Activities
    299. Wogonin Affecting Proliferation Activity of Human Lung Cancer A549 Cell in Vitro
    300. Wogonin affects proliferation and the energy metabolism of SGC‑7901 and A549 cells
    301. Wogonin Alleviates Hyperglycemia Through Increased Glucose Entry into Cells Via AKT/GLUT4 Pathway
    302. Wogonin ameliorate complete Freund’s adjuvant induced rheumatoid arthritis via targeting NF‐κB/MAPK signaling pathway
    303. Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice
    304. Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway
    305. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and …
    306. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK …
    307. Wogonin and Its Analogs
    308. Wogonin and neobaicalein from Scutellaria litwinowii roots are apoptotic for HeLa cells
    309. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1
    310. Wogonin and related natural flavones overcome TRAIL-resistance of tumors by down-regulation of c-FLIP and Up-regulation of TRAIL-R2 expression
    311. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c …
    312. Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU. 1 pathway
    313. Wogonin Attenuates Allergic Neutrophilic Airway Inflammation By Inducing Neutrophil Apoptosis
    314. Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties
    315. Wogonin attenuates endotoxin‐induced prostaglandin E2 and nitric oxide production via Src‐ERK1/2‐NFκB pathway in BV‐2 microglial cells
    316. Wogonin attenuates etoposide-induced oxidative DNA damage and apoptosis via suppression of oxidative DNA stress and modulation of OGG1 expression
    317. Wogonin attenuates high glucose-induced human breast cancer cell MCF-7 viability, migration and invasion via the expression of AKT, PKCδ and p38 MAPK
    318. Wogonin attenuates hippocampal neuronal loss and cognitive dysfunction in Trimethyltin-intoxicated rats
    319. Wogonin attenuates inflammation by activating PPAR-γ in alcoholic liver disease
    320. Wogonin attenuates isoprenaline-induced myocardial hypertrophy in mice by suppressing the PI3K/akt pathway
    321. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
    322. Wogonin attenuates nasal polyp formation by inducing eosinophil apoptosis through HIF-1α and survivin suppression
    323. Wogonin attenuates ovalbumin antigen-induced neutrophilic airway inflammation by inhibiting th17 differentiation
    324. Wogonin attenuates the deleterious effects of traumatic brain injury in anesthetized Wistar rats
    325. Wogonin but not Nor-Wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages
    326. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP …
    327. Wogonin enhances intracellular adiponectin levels and suppresses adiponectin secretion in 3T3-L1 adipocytes
    328. Wogonin enhances tumor necrosis factor-related apoptosis-inducing ligand’s antitumor activity in vivo through H2O2-mediated downregulation of X-linked inhibitor of …
    329. Wogonin exacerbates the cytotoxic effect of oxaliplatin by inducing nitrosative stress and autophagy in human gastric cancer cells
    330. Wogonin exerts anti-inflammatory effect by disrupting keap-1/Nrf2 interactions and activating Nrf2 in human OA chondrocytes
    331. Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung …
    332. Wogonin hosted@ β-cyclodextrin: structural, electronic and nuclear studies
    333. Wogonin improves functional neuroprotection for acute cerebral ischemia in rats by promoting angiogenesis via TGF-β1
    334. Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-κB signaling after experimental traumatic brain injury
    335. Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway
    336. Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer.
    337. Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer’s disease
    338. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63
    339. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner
    340. Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT
    341. Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCδ phosphorylation
    342. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells
    343. Wogonin induced mitochondrial dysfunction and endoplasmic reticulum stress in human malignant neuroblastoma cells via IRE1α-dependent pathway
    344. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K–AKT pathway
    345. Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway
    346. Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells
    347. Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells
    348. Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells
    349. Wogonin induces apoptosis in RPMI 8226, a human myeloma cell line, by downregulating phospho-Akt and overexpressing Bax
    350. Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells
    351. Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells
    352. Wogonin induces cross‐regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells
    353. Wogonin induces differentiation and neurite outgrowth of neural precursor cells
    354. Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation
    355. Wogonin induces G1 phase arrest through inhibiting Cdk4 and cyclin D1 concomitant with an elevation in p21Cip1 in human cervical carcinoma HeLa cells
    356. Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells
    357. Wogonin induces retinal neuron-like differentiation of bone marrow stem cells by inhibiting Notch-1 signaling
    358. Wogonin induces the apoptosis of Lung cancer cells and its mechanisms research [J]
    359. Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up‐regulates phospholipid scramblase 1 gene expression
    360. Wogonin influences vascular permeability via Wnt/β‐catenin pathway
    361. Wogonin inhib its cytokineproduction and cell migration in microglial cells via NF-kB, not cAMP, dependent pathways
    362. Wogonin Inhibited Oral Squamous Cell Carcinoma Cells Proliferation and Invasion Through Modulation of the Wnt/β-Catenin Signaling Pathway
    363. Wogonin Inhibits Angiogenesis Via a c-Myc/Hif-1α–dependent Pathway in Multiple Myeloma
    364. Wogonin inhibits cell cycle progression by activating the glycogen synthase kinase-3 beta in hepatocellular carcinoma
    365. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells
    366. Wogonin Inhibits Growth of Mantle Cell Lymphoma Cells through Nuclear Factor-κB Signaling Pathway
    367. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-κB signaling pathway
    368. Wogonin inhibits H2O2-induced vascular permeability through suppressing the phosphorylation of caveolin-1
    369. Wogonin inhibits IGF-1-stimulated cell growth and estrogen receptor α expression in breast adenocarcinoma cell and angiogenesis of chick chorioallantoic membrane
    370. Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, not VEGFR-2
    371. Wogonin inhibits inducible prostaglandin E2 production in macrophages
    372. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion
    373. Wogonin inhibits LPS-induced inflammatory responses in rat dorsal root ganglion neurons via inhibiting TLR4–MyD88–TAK1-mediated NF-κB and MAPK signaling …
    374. Wogonin inhibits LPS-induced tumor angiogenesis via suppressing PI3K/Akt/NF-κB signaling
    375. Wogonin inhibits LPS-induced vascular permeability via suppressing MLCK/MLC pathway
    376. Wogonin inhibits microglial cell migration via suppression of nuclear factor-kappa B activity
    377. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis
    378. Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells
    379. Wogonin inhibits osteoclast differentiation by inhibiting NFATc1 translocation into the nucleus
    380. Wogonin inhibits osteoclast formation induced by lipopolysaccharide
    381. Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR …
    382. Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis
    383. Wogonin Inhibits Transforming Growth Factor β1–induced Extracellular Matrix Production via the p38/activator Protein 1 Signaling Pathway in Nasal Polyp–derived …
    384. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein
    385. Wogonin inhibits tumor-derived regulatory molecules by suppressing STAT3 signaling to promote tumor immunity
    386. Wogonin inhibits Varicella-Zoster (shingles) virus replication via modulation of type I interferon signaling and adenosine monophosphate-activated protein kinase …
    387. Wogonin inhibits WEHI-3 leukemia cells in Blab/C mice In Vivo
    388. Wogonin mitigates intervertebral disc degeneration through the Nrf2/ARE and MAPK signaling pathways
    389. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro
    390. Wogonin modulates hydroperoxide-induced apoptosis via PI3K/Akt pathway in retinal pigment epithelium cells
    391. Wogonin overcomes cisplatin resistance of head and neck cancer by targeting antioxidant defense mechanisms
    392. Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species
    393. Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects
    394. Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and …
    395. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway
    396. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis
    397. Wogonin prevents glucocorticoid-induced thymocyte apoptosis without diminishing its anti-inflammatory action
    398. Wogonin prevents immunosuppressive action but not anti‐inflammatory effect induced by glucocorticoid
    399. Wogonin prevents lipopolysaccharide‐induced acute lung injury and inflammation in mice via peroxisome proliferator‐activated receptor gamma‐mediated …
    400. Wogonin prevents rat dorsal root ganglion neurons death via inhibiting tunicamycin-induced ER stress in vitro
    401. Wogonin prevents TLR4-NF-κB-medicated neuro-inflammation and improves retinal ganglion cells survival in retina after optic nerve crush
    402. Wogonin promotes cholesterol efflux by increasing protein phosphatase 2B-dependent dephosphorylation at ATP-binding cassette transporter-A1 in macrophages
    403. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis
    404. Wogonin protects human retinal pigment epithelium cells from LPS-induced barrier dysfunction and inflammatory responses by regulating the TLR4/NF-κB …
    405. Wogonin protects rat dorsal root ganglion neurons against tunicamycin-induced ER stress through the PERK-eIF2α-ATF4 signaling pathway
    406. Wogonin reduces infarct size and improves ventricular function in chronic myocardial ischemia rats
    407. Wogonin regulated cell proliferation and apoptosis, and repressed miR-128 expression in human glioblastoma cell line U87
    408. Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/NF-κB inactivation
    409. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF‐1α and glycolysis, by inhibiting PI3K/Akt signaling pathway
    410. Wogonin reverses multi-drug resistance of human myelogenous leukemia K562/A02 cells via downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling …
    411. Wogonin sensitizes resistant malignant cells to TNFα-and TRAIL-induced apoptosis
    412. Wogonin suppresses cellular proliferation and expression of monocyte chemoattractant protein 1 in Peyronie’s plaque‐derived cells
    413. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL‐6/STAT3 signaling pathway
    414. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro
    415. Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways
    416. Wogonin suppresses osteopontin expression in adipocytes by activating PPARα
    417. Wogonin suppresses stem cell-like traits of CD133 positive osteosarcoma cell via inhibiting matrix metallopeptidase-9 expression
    418. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes: suppressive effect of Wogonin on mite antigen …
    419. Wogonin suppresses the activity of matrix metalloproteinase-9 and inhibits migration and invasion in human hepatocellular carcinoma
    420. Wogonin suppresses the LPS‑enhanced invasiveness of MDA‑MB‑231 breast cancer cells by inhibiting the 5‑LO/BLT2 cascade
    421. Wogonin suppresses the production of breast cancer-derived osteolytic factors
    422. Wogonin suppresses TNF-α-induced MMP-9 expression by blocking the NF-κB activation via MAPK signaling pathways in human aortic smooth muscle cells
    423. Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2
    424. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent …
    425. Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling …
    426. Wogonin, 5, 7‐dihydroxy‐8‐methoxyflavone as oestrogenic and anti‐implantational agent in the rat
    427. Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase‐2 gene expression in human lung epithelial cancer cells
    428. Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways.
    429. Wogonin, a natural and biologically-active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T-and B-cells
    430. Wogonin, a natural flavonoid, intercalates with genomic DNA and exhibits protective effects in IL-1β stimulated osteoarthritis chondrocytes
    431. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in …
    432. Wogonin, a plant flavone from Scutellariae radix, attenuated ovalbumin-induced airway inflammation in mouse model of asthma via the suppression of IL-4/STAT6 …
    433. Wogonin, a plant flavone, potentiates etoposide‐induced apoptosis in cancer cells
    434. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells
    435. Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by …
    436. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and …
    Share
    0
    INTERSTELLAR BLEND
    INTERSTELLAR BLEND

    Related posts

    February 20, 2020

    Wedelolactone


    Read more
    February 20, 2020

    Trichostatin A


    Read more
    February 20, 2020

    Taraxasterol


    Read more

    Comments are closed.

    Recent Posts

    • ANTI COVID-19 EFFECTS OF FLAVONOIDS AND POLYPHENOLS (1000 SCIENTIFIC STUDIES)
    • Myostatin Inhibition Preserves Muscle
    • Myostatin inhibition and Muscle growth
    • Phytoecdysteroids
    • PPARY2
    © 2021 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer